← Eichor
Condition: Anaplastic Meningioma Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Anaplastic Meningioma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Apatinib in the Treatment of Recurrent Atypical/malignant Meningioma in Adults
NA · 1 location(s) · Beijing Sanbo Brain Hospital · NCT04501705
Adjuvant Hypofractionated Stereotactic Radiosurgery for Intermediate-risk Meningioma
NA · 1 location(s) · University of California, San Francisco · NCT06557512
NK Cell Therapy for Malignant Solid Brain Tumors
NA · 4 location(s) · Peking University Third Hospital · NCT07552233
Predictive Factors for Survival in Aggressive Meningiomas
NA · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT05793034
SIMPLIFication of Care Pathways for Patients With Rare Brain Tumors Through Artificial Intelligence
NA · 2 location(s) · Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta · NCT06878469
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3
Phase 2 · 8 location(s) · Northwestern University · NCT02847559
Regorafenib for Recurrent Meningioma (MIRAGE Trial)
Phase 2 · 17 location(s) · Istituto Oncologico Veneto IRCCS · NCT06275919
Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
Phase 1 · 1 location(s) · Jazz Pharmaceuticals · NCT04541082
A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma
Phase 2 · 12 location(s) · Exelixis · NCT07428616
Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors
Phase 1/Phase 2 · 4 location(s) · Nationwide Children's Hospital · NCT05278208
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.